Work

Association of IL7 germline variants with immune-related adverse events (irAEs) in cancer patients (pts) treated with immune checkpoint inhibitors (ICIs).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.12129

Authors: Eddy Saad, Jinhyeon An, Elnaz Mirzaei Mehrabad, Chris Labaki, Renee Maria Saliby, Karl Semaan, Marc Eid, Marc Machaalani, Razane El Hajj Chehade, Clara Steiner, Rashad Nawfal, Emre Yekeduz, Parantu K. Shah, Aarti Asnani, Maxine Sun, Eliezer Mendel Van Allen, Jung Kyoon Choi, Sook Ryun Park, Alexander Gusev, Toni K. Choueiri

Institutions: Dana-Farber Cancer Institute, Korea Advanced Institute of Science and Technology, Huntsman Cancer Institute, Beth Israel Deaconess Medical Center, Yale Cancer Center, EMD Serono, Inc. (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410808308

Cites:

Cited by: 1

Related to: 10